Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s diagnostics and research industry, is positioning itself for growth despite current financial hurdles. With a market capitalization of $2.38 billion, Neogen stands out for its dual focus on Food Safety and Animal Safety, catering to a diverse array of markets ranging from food and beverage to animal health and genomics services.

At a current stock price of $10.94, Neogen has reached the upper end of its 52-week range, which spans from $4.39 to $10.94. This upward trajectory is underpinned by a 6.64% potential upside, as suggested by analysts’ average target price of $11.67. The consensus reflects a cautiously optimistic outlook, with two buy…